MUCOSAL INFECTION WITH ARENAVIRUS
MUCOSAL INFECTION WITH ARENAVIRUS
批准号:
6188665
负责人:
Igor S. Lukashevich
金额:
$5.05万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2000-11-30
关键词:
Macaca mulatta active immunization antiviral antibody cellular immunity communicable disease transmission cytotoxic T lymphocyte disease /disorder model emerging infectious disease flow cytometry humoral immunity immunocytochemistry immunologic memory in situ hybridization interferon gamma lymphocytic choriomeningitis virus mucosa mucosal immunity pathologic process serology /serodiagnosis species difference virulence virus RNA virus antigen virus load virus replication
中文摘要
沙粒病毒是啮齿动物传播的病毒,当传播给人类时会导致致命的疾病。非洲的拉沙热病毒和玻利维亚的马丘波病毒是过去几年中引起显著暴发的两种沙粒病毒。 沙粒病毒的原型,淋巴细胞性脉络丛脑膜炎病毒(LCMV),经常被用来研究近交系小鼠的细胞介导的免疫。 然而,鼠感染是用于人沙粒病毒病的不合适的模型,因为人疾病更具毒性并且具有不同的致病机制。 此外,实验感染主要采用非肠道接种途径,粘膜接种(通过吸入或摄入)是最常见的自然感染途径。对其他病毒系统的研究,特别是对艾滋病的猴模型的研究,表明接种途径深刻地影响了发病机制和对感染的免疫反应。由于对粘膜接种后沙粒病毒感染知之甚少,我们提出了一项试点研究,将我们的小鼠粘膜研究扩展到非人灵长类动物。 在恒河猴胃内接种后,我们将收集有关病毒水平和分布、免疫应答的时间过程和病理进展的信息。 我们将采用LCMV感染的猴子,这非常类似于拉沙热病毒感染的猴子。 我们将测试的假设,粘膜LCMV感染的恒河猴的几个特点,小鼠粘膜LCMV感染,但根本不同的发病机制。 我们收集的信息对于人类疾病和影响非人类灵长类动物的疾病(例如,胼胝体增生性肝炎,一种新出现的圈养新世界灵长类动物的疾病)。 关于免疫应答时程的信息将为疫苗引起的免疫应答提供标志。 因此,这些信息将作为开发针对粘膜沙粒病毒感染的粘膜疫苗和药物治疗的基础。
英文摘要
Arenaviruses are rodent-borne viruses that cause fatal illness when transmitted to man. Lassa fever virus in Africa and Machupo virus in Bolivia are two arenaviruses that have caused noteable outbreaks in the last few years. The prototype arenavirus, lymphocytic choriomeningitis virus (LCMV), has frequently been used to study cell-mediated immunity in inbred mice. However murine infection is an inappropriate model for arenavirus disease in man, because human disease is more virulent and has a different pathogenic mechanism. Furthemore, experimental infections have employed primarily parenteral routes of inoculation, and mucosal inoculation (through inhalation or ingestion) is the most frequent natural route of infection. Studies with other viral systems, particularly the monkey model for AIDS, illustrate that the route of inoculation profoundly influences the pathogenesis and immune responses to infection. Since little is known about arenavirus infection after mucosal inoculation, we propose a pilot study to extend our murine mucosal studies to the nonhuman primate. After intragastric inoculation of rhesus macaques we will collect information about the level and distribution of virus, the timecourse of immune responses, and the progression of pathology. We will employ LCMV infection of monkeys, which strongly resembles Lassa fever virus infection of monkeys. We will test the hypothesis that mucosal LCMV infection of the rhesus macaque shares several features of murine mucosal LCMV infection, but differs fundamentally in pathogenesis. The information we collect will be important for human disease and for diseases affecting nonhuman primates (e.g., callitriched hepatitis, an emerging disease of captive New World primates). The information about immune response timecourse will provide landmarks for vaccine-elicited immune responses. Thus, this information will serve as the basis for developing mucosal vaccines and pharmacological treatments that target mucosal arenavirus infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of New Bivalent Cross-Protective Arenaviral Vaccines
-
批准号:8249031
-
项目类别:
-
资助金额:$82.27万
-
财政年份:2011
-
负责人:Igor S. Lukashevich
-
依托单位:
Development of New Bivalent Cross-Protective Arenaviral Vaccines
-
批准号:8076666
-
项目类别:
-
资助金额:$12.21万
-
财政年份:2011
-
负责人:Igor S. Lukashevich
-
依托单位:
Development of New Bivalent Cross-Protective Arenaviral Vaccines
-
批准号:8389370
-
项目类别:
-
资助金额:$74.59万
-
财政年份:2011
-
负责人:Igor S. Lukashevich
-
依托单位:
Development of New Bivalent Cross-Protective Arenaviral Vaccines
-
批准号:8649000
-
项目类别:
-
资助金额:$72.77万
-
财政年份:2011
-
负责人:Igor S. Lukashevich
-
依托单位:
Development of New Bivalent Cross-Protective Arenaviral Vaccines
-
批准号:8445279
-
项目类别:
-
资助金额:$77.34万
-
财政年份:2011
-
负责人:Igor S. Lukashevich
-
依托单位:
IMMUNOGENICITY OF RECOMBINANT YF17D-LASSA VACCINE IN COMMON MARMOSETS
-
批准号:7715535
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2008
-
负责人:Igor S. Lukashevich
-
依托单位:
Recombinant Yellow Fever 17D-Lassa Vaccine
-
批准号:7409716
-
项目类别:
-
资助金额:$53.54万
-
财政年份:2007
-
负责人:Igor S. Lukashevich
-
依托单位:
Recombinant Yellow Fever 17D-Lassa Vaccine
-
批准号:7485427
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2007
-
负责人:Igor S. Lukashevich
-
依托单位:
MOP/LAS chimeric vaccine against Lassa fever
-
批准号:6985337
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2003
-
负责人:Igor S. Lukashevich
-
依托单位:
MOP/LAS chimeric vaccine against Lassa fever
-
批准号:6829668
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2003
-
负责人:Igor S. Lukashevich
-
依托单位:
MOP/LAS chimeric vaccine against Lassa fever
-
批准号:7552315
-
项目类别:
-
资助金额:$19.48万
-
财政年份:2003
-
负责人:Igor S. Lukashevich
-
依托单位:
MOP/LAS chimeric vaccine against Lassa fever
-
批准号:6725240
-
项目类别:
-
资助金额:$43.15万
-
财政年份:2003
-
负责人:Igor S. Lukashevich
-
依托单位:
MOP/LAS chimeric vaccine against Lassa fever
-
批准号:7154789
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2003
-
负责人:Igor S. Lukashevich
-
依托单位:
Mopeia/Lassa Virus Reassortants as Lassa Fever Vaccines
-
批准号:6508911
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2002
-
负责人:Igor S. Lukashevich
-
依托单位:
MUCOSAL INFECTION WITH ARENAVIRUS
-
批准号:2806791
-
项目类别:
-
资助金额:$13.85万
-
财政年份:1999
-
负责人:Igor S. Lukashevich
-
依托单位:
MUCOSAL INFECTION WITH ARENAVIRUS
-
批准号:6474006
-
项目类别:
-
资助金额:$9.19万
-
财政年份:1999
-
负责人:Igor S. Lukashevich
-
依托单位:
海外基金